The success of maternal immunisation has been demonstrated by the use of tetanus vaccination programmes in developing countries. Many more diseases that can occur during the first few weeks of life could be prevented by this strategy. The science to support this idea is available, but there is some way to go before it is put into practice. Research is underway with a number of vaccines, including one that protects against group B streptococcus (GBS) infections. The current status of development of this vaccine was described at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [ New Orleans, US; September 1996 ].
This is a preview of subscription content, access via your institution.
About this article
Cite this article
Higgins, G. Maternal immunisation is a must. Inpharma Wkly. 1056, 3–4 (1996). https://doi.org/10.2165/00128413-199610560-00003
- 36th Interscience
- Neonatal Tetanus
- Maternal Immunisation
- Major Clinical Significance